Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines

International Journal of Cancer

Volumn 135, Issue 12, 2014, Pages 2795-2803

  Liu, Wei ^a   Li, Li ^b   Li, Weidong ^a  

^a INSTITUTE OF AVIATION MEDICINE   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Cancer; Cell line; Drug resistance; Module; Prognosis additional supporting information may be found in the online version of this article

Indexed keywords

ANTINEOPLASTIC AGENT;

CYTOSKELETON; DNA MICROARRAY; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; NEOPLASM; PROGNOSIS; RNA SPLICING; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYTOSKELETON; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RNA SPLICING; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84908672870     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28935     Document Type: Article

References (33)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-74.
2. .Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-74.
3. Park YY, Kim K, Kim SB, et al. Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1in breast cancer. EMBO Mol Med 2012;4: 52-67.
4. Ivliev AE, t Hoen PA, Sergeeva MG. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma. Cancer Res 2010;70:10060-70.
5. AE Ivliev , t Hoen PA, Sergeeva MG. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma. Cancer Res 2010;70:10060-70.
6. Hu Y, Wu G, Rusch M, et al. Integrated crossspecies transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci USA 2012; 109:3184-9.
7. Rhodes DR, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004;101:9309-14.
8. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Mining for regulatory programs in the cancer transcriptome. Nat Genet 2005;37:579-83.
9. Segal E, Friedman N, Koller D, et al. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004;36:1090-8.
10. Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
11. Carter SL, Eklund AC, Kohane IS, et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38:1043-8.
12. Zhang J, Lu K, Xiang Y, et al. Weighted frequent gene co-expression network mining to identify genes involved in genome stability. PLoS Comput Biol 2012;8:e1002656.
13. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92.
14. Ponten F, Gry M, Fagerberg L, et al. A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol 2009;5:337.
15. Wang A, Huang K, Shen Y, et al. Functional modules distinguish human induced pluripotent stem cells from embryonic stem cells. Stem Cells Dev 2011;20:1937-50.
16. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559.
17. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005;4:Article17.
18. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
19. Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012;483:570-5.
20. Yang W, Soares J, Greninger P, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 2013;41:D955-61.
21. Fuller T, Langfelder P, Presson A, et al. Review of weighted gene coexpression network analysis. In: Lu HH-S, Sch€olkopf B, Zhao H. Handbook ofstatistical bioinformatics. Berlin, Heidelberg: Springer, 2011. 369-88.
22. Arteaga CL. Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 2002;7(Suppl 4):31-9.
23. Gross JM, Yee D. How does the estrogen receptor work? Breast Cancer Res 2002;4:62-4.
24. Hughes AK, Cichacz Z, Scheck A, et al. Immunosignaturing can detect products from molecular markers in brain cancer. PLoS One 2012;7:e40201.
25. Minguez B, Hoshida Y, Villanueva A, et al. Geneexpression signature of vascular invasion in hepatocellular carcinoma. J Hepatol 2011;55:1325-31.
26. Pena C, Cespedes MV, Lindh MB, et al. STC1expression by cancer-associated fibroblasts drivesmetastasis of colorectal cancer. Cancer Res 2013; 73:1287-97.
27. Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst 2013;105:452-8.
28. Finn RS, Aleshin A, Dering J, et al. Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro. Hepatology 2013;57: 1838-46.
29. Jeong H, Mason SP, Barabasi AL, et al. Lethality and centrality in protein networks. Nature 2001; 411:41-2.
30. Balani P, Boulaire J, Zhao Y, et al. High mobility group box2 promoter-controlled suicide geneexpression enables targeted glioblastoma treatment. Mol Ther 2009;17:1003-11.
31. Stros M, Ozaki T, Bacikova A, et al. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J Biol Chem 2002;277:7157-64.
32. Cullen KJ, Yang Z, Schumaker L, et al. Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J Bioenerg Biomembr 2007;39:43-50.
33. Azmi AS, Wang Z, Philip PA, et al. Proof of concept: Network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Mol Cancer Ther 2010;9:3137-44.